Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Become a member for free
Sign up
New member
Sign up for FREE
New customer
Discover our services
English (USA)
English (UK)
English (Canada)
Deutsch (Deutschland)
Deutsch (Schweiz)
Español
Français (France)
Français (Suisse)
Italiano
Nederlands (Nederland)
Nederlands (België)
MARKETS
Equities
United States
North America
Europe
Asia
Middle East
More Equities
Indexes
S&P 500
DOW JONES
NASDAQ 100
EURO STOXX 50
NIKKEI 225
More Indexes
Currency / Forex
USD / EUR
USD / CAD
USD / MXN
USD / BRL
USD / INR
More Currencies
Commodities
GOLD
CRUDE OIL (WTI)
CRUDE OIL (BRENT)
SILVER
PLATINUM
More Commodities
Cryptocurrencies
BITCOIN
ETHEREUM
Trackers & ETF
Rankings and News
Advanced Search
NEWS
Latest News
Companies
Markets
Economy
Currency / Forex
Commodities
Interest Rates
Finance Pro.
Business Leaders
Cryptocurrencies
Cybersecurity
Economic Calendar
Listed companies
Analyst Reco.
Rumors
IPOs
Capital Markets Transactions
New Contracts
Profit Warnings
Appointments
Press Releases
Events
Security Transactions
Financial Calendar
Sector News
Energy
Basic Materials
Industrials
Consumer Cyclical
Consumer Non-Cyclical
Financials
Healthcare
Technology
Real Estate
Utilities
ANALYSIS
All Analysis
Must Read
Daily Briefing
Weekly market update
Stock Trading Strategies
STOCK PICKS
All Stock Picks
Subscribe
PORTFOLIOS
My Portfolio
Virtual Portfolios
MarketScreener Portfolios
USA Portfolio
European Portfolio
Asian Portfolio
WATCHLISTS
My Watchlists
Watchlists
My previous session
My most visited
Most popular
Investment Style
Yield stocks
Growth stocks
Quality stocks
Momentum stocks
Undervalued stocks
ESG stocks
Investment Themes
Luxury
Strategic Metals
The Vegan Market
Artificial Intelligence
Financial Data
Place your bets
RANKINGS
Top News
Most Read News
Hot News
Top Fundamentals
Top Capitalization
Top Yield
Top PER
Top Consensus
Top Fundamentals
Top ranking ESG
Top Technicals
Top RSI
Unusual volumes
Top Gaps
Top STIM
Breakouts
Trends
Top Movers
Top USA
Top Canada
Top U.K.
Top Germany
Top Europe
Top Asia
SCREENERS
Investment Themes
Artificial Intelligence
Europe's family businesses
In Vino Veritas
Water
Cybersecurity
Ageing Population
Technical Rankings
Oversold stocks
Overbought stocks
Close to resistance
Close to support
Accumulation Phases
Most volatile stocks
Fundamental Rankings
Top Investor Rating
Top Trading Rating
Top Consensus
Growth stocks
Yield stocks
Low valuations
Stock Screener Home
My Screeners
All my stocks
Watchlists
Virtual Portfolios
TOOLS
MarketScreener tools
Stock Screener
iPhone App
Expert tools
Stock Screener PRO
Portfolio Creator
Event Screener
Tools
Dynamic Chart
Financial Calendar
Economic Calendar
Sector Research
Currency Converter
ProRealTime Trading
OUR SERVICES
MarketScreener Portfolios
European Portfolio
USA Portfolio
Asian Portfolio
Our Stock Picks
Thematic Investment Lists
Stock Screener
Homepage
Equities
United States
Nasdaq
Novavax, Inc.
News
Analyst Reco.
NVAX
US6700024010
NOVAVAX, INC.
(NVAX)
Add to my list
Report
Real-time Estimate Cboe BZX -
05/26 01:49:18 pm
46.865
USD
+1.59%
05:47a
Novavax Announces Participation in Oxford University Com-COV3 Booster Trial of COVID-19 Vaccines in Adolescents Aged 12 Through 15
AQ
05/24
Indian vaccine giant Serum plans African plant in global expansion
RE
05/23
Novavax Files in the European Union for Expanded Conditional Marketing Authorization of COVID-19 Vaccine as a Booster in Individuals Aged 18 and Over
AQ
Summary
Quotes
Charts
News
Ratings
Calendar
Company
Financials
Consensus
Revisions
Summary
Most relevant
All News
Analyst Reco.
Other languages
Press Releases
Official Publications
Sector news
MarketScreener Strategies
Analyst Recommendations on NOVAVAX, INC.
05/20
BofA Securities Initiates Coverage on Novavax With Underperform Rating
MT
05/11
B. Riley Lowers Novavax's Price Target to $181 from $203, Keeps Buy Rating
MT
04/26
B. Riley Lowers Novavax's Price Target to $203 from $250, Notes Relatively Lowered Pene..
MT
03/03
HC Wainwright Adjusts Price Target on Novavax to $207 From $294, Reiterates Buy Rating
MT
03/02
B. Riley Lowers Novavax's PT to $250 from $265 On Supply/Distribution, Notes Higher Nea..
MT
02/23
B. Riley Lowers Novavax's Price Target to $265 from $315 on Reduced Near-Term Estimates..
MT
02/15
ANALYST RECOMMENDATIONS
: Enbridge, GSK, PepsiCo, Moody's, Novavax...
02/14
Cantor Fitzgerald Adjusts Price Target on Novavax to $174 From $282, Reiterates Overwei..
MT
01/21
Cowen Starts Novavax at Outperform With $150 Price Target
MT
01/04
B. Riley Raises Novavax's PT to $315 from $305, Says Recent Volatility Presents Buying ..
MT
2021
ANALYST RECOMMENDATIONS
: Caterpillar, Cineworld, JD Sports, Microsoft, Nike...
2021
JPMorgan Adjusts Novavax's Price Target to $209 from $172, Keeps Neutral Rating
MT
2021
ANALYST RECOMMENDATIONS
: Berkshire Hathaway, eBay, General Electric, HSBC, Novavax...
2021
NOVAVAX
: B. Riley Raises Novavax's PT to $305 from $286, Notes Potential to Supply Higher..
MT
2021
NOVAVAX
: Cantor Fitzgerald Adjusts Novavax PT to $272 From $217, Maintains Overweight Rat..
MT
2021
NOVAVAX
: B. Riley Lowers Novavax' Price Target to $286 from $365, Notes Weakening Competi..
MT
2021
NOVAVAX
: Cantor Fitzgerald Adjusts Price Target on Novavax to $217 From $338, Maintains O..
MT
2021
NOVAVAX
: HC Wainwright Adjusts Price Target on Novavax to $294 From $317, Maintains Buy R..
MT
2021
NOVAVAX
: JPMorgan Cuts Novavax to Neutral From Overweight, Price Target to $161 From $285
MT
2021
NOVAVAX
: Jefferies Adjusts Price Target on Novavax to $235 From $310, Maintains Buy Ratin..
MT
2021
NOVAVAX
: B. Riley Lowers Novavax' PT to $365 from $397, Says AstraZeneca's AZD1222 Now Co..
MT
2021
NOVAVAX
: HC Wainwright & Co. Adjusts Price Target on Novavax to $317 From $207, Maintains..
MT
2021
NOVAVAX
: B. Riley Raises Novavax' Price Target to $397 from $334 on Continued Strength in..
MT
2021
NOVAVAX
: B. Riley Adjusts Novavax' Price Target to $334 From $223, Keeps Buy Rating
MT
2021
NOVAVAX
: JP Morgan Adjusts Price Target for Novavax to $295 From $215, Maintains Overweig..
MT
2021
NOVAVAX
: Cantor Fitzgerald Adjusts Novavax PT to $248 From $211, Maintains Overweight Rat..
MT
2020
NOVAVAX
: Jefferies Starts Novavax at Buy With $200 Price Target
MT
2020
Pfizer Says Covid Vaccine Is 95% Effective in Final Data, Will Seek Authorization
DJ
2020
Pfizer's Covid-19 Vaccine 95% Effective in Final Results, Company to Seek Approval With..
DJ
2020
NOVAVAX
: HC Wainwright Adjusts Novavax's Price Target to $207 From $290, Keeps at Buy
MT
2020
Drugmakers see long road ahead in coronavirus vaccine race
RE
Analysis
Australia says no to 16-year-old forklift drivers as remedy to COVID supply chain pain
More Must read
Upcoming event on NOVAVAX, INC.
06/16/22
Annual General Meeting
Company calendar
Upcoming sector events
07/26/22
IQVIA HOLDINGS INC.
: Interim 2022 Earnings Release (Projected)
07/27/22
LONZA GROUP AG
: Interim 2022 Earnings Release (Projected)
07/28/22
SEAGEN INC.
: Interim 2022 Earnings Release (Projected)
08/10/22
MODERNA, INC.
: Interim 2022 Earnings Release (Projected)
More events
Sector
Healthcare
Pharmaceuticals & Medical Research
Biotechnology & Medical Research
Biotechnology & Medical Research
Other Biotechnology & Medical Research
Master